Oppenheimer & Co’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.96M Buy
58,595
+367
+0.6% +$22.5K 0.03% 513
2026
Q1
$3.8M Buy
58,228
+12,191
+26% +$892K 0.05% 400
2025
Q4
$3.71M Buy
46,037
+6,788
+17% +$546K 0.05% 372
2025
Q3
$3.22M Sell
39,249
-547
-1% -$47.4K 0.04% 461
2025
Q2
$3.63M Sell
39,796
-1,533
-4% -$137K 0.05% 402
2025
Q1
$3.78M Sell
41,329
-2,479
-6% -$216K 0.06% 360
2024
Q4
$3.73M Buy
43,808
+2,447
+6% +$215K 0.06% 355
2024
Q3
$3.62M Sell
41,361
-664
-2% -$55.9K 0.06% 362
2024
Q2
$3.32M Buy
42,025
+10,306
+32% +$847K 0.05% 374
2024
Q1
$2.87M Sell
31,719
-77
-0.2% -$7.02K 0.05% 417
2023
Q4
$2.79M Buy
31,796
+10,391
+49% +$866K 0.05% 408
2023
Q3
$1.81M Sell
21,405
-3,387
-14% -$306K 0.04% 491
2023
Q2
$2.45M Sell
24,792
-3,091
-11% -$291K 0.05% 418
2023
Q1
$2.68M Sell
27,883
-515
-2% -$47.7K 0.06% 379
2022
Q4
$2.58M Buy
28,398
+1,958
+7% +$167K 0.06% 373
2022
Q3
$2.1M Buy
26,440
+4,815
+22% +$408K 0.05% 413
2022
Q2
$1.8M Buy
21,625
+5,611
+35% +$463K 0.04% 494
2022
Q1
$1.32M Sell
16,014
-1,277
-7% -$100K 0.02% 635
2021
Q4
$1.29M Buy
17,291
+1,166
+7% +$87.5K 0.02% 678
2021
Q3
$1.22M Buy
16,125
+11,177
+226% +$865K 0.02% 671
2021
Q2
$383K Buy
+4,948
New +$382K 0.01% 1136
2019
Q3
Sell
-3,226
Closed -$200K 1277
2019
Q2
$200K Buy
+3,226
New +$186K 0.01% 1190
2016
Q1
Sell
-16,920
Closed -$923K 1262
2015
Q4
$923K Sell
16,920
-275
-2% -$15.8K 0.03% 577
2015
Q3
$978K Sell
17,195
-255
-1% -$14.6K 0.03% 585
2015
Q2
$953K Sell
17,450
-500
-3% -$27.5K 0.03% 644
2015
Q1
$976K Sell
17,950
-58
-0.3% -$2.93K 0.03% 632
2014
Q4
$840K Sell
18,008
-442
-2% -$20.7K 0.02% 664
2014
Q3
$846K Sell
18,450
-8,118
-31% -$380K 0.03% 660
2014
Q2
$1.23M Sell
26,568
-10,687
-29% -$503K 0.04% 546
2014
Q1
$1.73M Buy
37,255
+5,355
+17% +$234K 0.05% 423
2013
Q4
$1.32M Buy
+31,900
New +$1.25M 0.04% 475

Other funds holding DOX

Oppenheimer & Co's DOX Position: Q2 2026 in Review

Oppenheimer & Co increased its Amdocs (DOX) stake by 0.63% in Q2 2026, buying an estimated $22.5K and bringing the position to 58,595 shares worth $2.96M. The position accounts for 0.03% of the portfolio, ranked #513.

Oppenheimer & Co first reported a position in DOX in Q4 2013 and has held it in 31 quarters since. The position peaked at $3.8M in Q1 2026. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • Oppenheimer & Co held 58,595 shares of Amdocs worth $2.96M as of Q2 2026.
  • Oppenheimer & Co bought 367 Amdocs shares in Q2 2026, an estimated $22.5K.
  • Amdocs made up 0.03% of Oppenheimer & Co's portfolio in Q2 2026, its #513 holding.
  • Oppenheimer & Co first reported a position in Amdocs in Q4 2013 and has held it in 31 quarters since.
  • Oppenheimer & Co's Amdocs position peaked at $3.8M in Q1 2026.
  • 447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.